“Design and In Silico Evaluation of Novel 1,3,4-Oxadiazole Derivatives As Potential CYP51B Inhibitors Against Aspergillus Fumigatus”. 2026. Al Mustansiriyah Journal of Pharmaceutical Sciences 26 (3): 302-15. https://doi.org/10.32947/ajps.v26i3.1420.